EAACI Launches Global Campaign To Combat Antibiotic Allergy Mislabelling

KUALA LUMPUR, Aug 18 (Bernama) -- The European Academy of Allergy and Clinical Immunology (EAACI) has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow, marking the start of a global initiative to address mislabelling and its link to antimicrobial resistance (AMR).

In a statement, the association said inaccurate antibiotic allergy labels affect millions of patients worldwide, leading to avoidance of first-line treatments and increased reliance on second-line antibiotics, a practice that fuels AMR.

EAACI is calling on stakeholders, including healthcare providers, policymakers and educators, to promote accurate diagnosis and responsible antibiotic use.

“We are launching a movement, not a moment. Too many lives are impacted by unverified allergy labels that limit treatment options and worsen outcomes. Correcting labels means saving lives, now and in the future,” said EAACI president, Prof Maria Torres.

The campaign aims to raise awareness of the dangers of incorrect allergy labels, empower patients and healthcare professionals with tools and training, promote evidence-based evaluation protocols and encourage rational antibiotic prescribing.

Outdated, unverified or self-reported allergy labels often reduce treatment options and increase risks, EAACI noted. The campaign seeks to overcome these barriers through education, training and advocacy.

A short educational video and a Promotional Kit 2025 form the backbone of the initiative, offering resources to spread awareness across multiple platforms.

Launched under the slogan “Correct Labels, Better Lives”, the campaign invites professionals, institutions and the public to participate in global efforts to safeguard the long-term effectiveness of antibiotics.

-- BERNAMA